Related Experiment Video
Updated: Aug 11, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Influence of imprecision on ROC curve analysis for cardiac markers
Peter Kupchak1, Alan H B Wu, Farooq Ghani
1Nanogen, Point of Care Diagnostics Division, Toronto, Ontario, Canada.
Background:
There has been considerable debate regarding the impact of assay imprecision on the performance of cardiac biomarkers for diagnosis of acute coronary syndromes (ACS) and risk stratification for future adverse cardiac events.
Methods:
Using existing data from 2 published clinical trials, we used a resampling method to statistically introduce 5%, 10%, and 20% imprecision to results for B-type natriuretic peptide (BNP) and cardiac troponin I (cTnI) and examined its impact on ROC curve analysis.
Results:
Superimposition of artificial imprecision produced no significant difference in the area under the ROC curve observed for BNP for diagnosis of heart failure or for cTnI for 30-day risk stratification of patients with ACS.
Conclusion:
Assay imprecision does not appear to be a critical determinant in the interpretation of cardiac marker results for patients with heart disease.
Related Concept Videos
Receiver Operating Characteristic Plot
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...